Rituximab, Methotrexate, Procarbazine, and Vincristine Followed by Consolidation Reduced-Dose Whole-Brain Radiotherapy and Cytarabine in Newly Diagnosed Primary CNS Lymphoma: Final... von MORRIS, Patrick G, CORREA, Denise D, KARIMI, Sasan, CURRY, Richard, SHAH, Gaurav, ABREY, Lauren E, DEANGELIS, Lisa M, OMURO, Antonio, YAHALOM, Joachim, RAIZER, Jeffrey J, SCHIFF, David, GRANT, Barbara, GRIMM, Sean, LAI, Rose K, REINER, Anne S, PANAGEAS, Kathy

Volltext

A regulatory circuit of miR-125b/miR-20b and Wnt signalling controls glioblastoma phenotypes through FZD6-modulated pathways von Huang, Tianzhi, Alvarez, Angel A., Pangeni, Rajendra P., M. Horbinski, Craig, Lu, Songjian, Kim, Sung-Hak, James, C. David, J. Raizer, Jeffery, A. Kessler, John, Brenann, Cameron W., Sulman, Erik P., Finocchiaro, Gaetano, Tan, Ming, Nishikawa, Ryo, Lu, Xinghua, Nakano, Ichiro, Hu, Bo, Cheng, Shi-Yuan

Volltext

Historical benchmarks for medical therapy trials in surgery- and radiation-refractory meningioma: a RANO review von Kaley, Thomas, Barani, Igor, Chamberlain, Marc, McDermott, Michael, Panageas, Katherine, Raizer, Jeffrey, Rogers, Leland, Schiff, David, Vogelbaum, Michael, Weber, Damien, Wen, Patrick

Volltext

Randomized Phase II Study of Cilengitide, an Integrin-Targeting Arginine-Glycine-Aspartic Acid Peptide, in Recurrent Glioblastoma Multiforme von REARDON, David A, FINK, Karen L, SCHIFF, David, SHAPIRO, William R, BURDETTE-RADOUX, Susan, DROPCHO, Edward J, WITTEMER, Sabine M, NIPPGEN, Johannes, PICARD, Martin, BURTNABORS, L, MIKKELSEN, Tom, CLOUGHESY, Timothy F, O'NEILL, Alison, PLOTKIN, Scott, GLANTZ, Michael, RAVIN, Paula, RAIZER, Jeffrey J, RICH, Keith M

Volltext

Phase II study of monthly pasireotide LAR (SOM230C) for recurrent or progressive meningioma von Norden, Andrew D, Ligon, Keith L, Hammond, Samantha N, Muzikansky, Alona, Reardon, David A, Kaley, Thomas J, Batchelor, Tracy T, Plotkin, Scott R, Raizer, Jeffrey J, Wong, Eric T, Drappatz, Jan, Lesser, Glenn J, Haidar, Sam, Beroukhim, Rameen, Lee, Eudocia Q, Doherty, Lisa, Lafrankie, Debra, Gaffey, Sarah C, Gerard, Mary, Smith, Katrina H, McCluskey, Christine, Phuphanich, Surasak, Wen, Patrick Y

Volltext

Combined Immunochemotherapy With Reduced Whole-Brain Radiotherapy for Newly Diagnosed Primary CNS Lymphoma von SHAH, Gaurav D, YAHALOM, Joachim, CORREA, Denise D, LAI, Rose K, RAIZER, Jeffrey J, SCHIFF, David, LAROCCA, Renato, GRANT, Barbara, DEANGELIS, Lisa M, ABREY, Lauren E

Volltext

Phase II study of panobinostat in combination with bevacizumab for recurrent glioblastoma and anaplastic glioma von Lee, Eudocia Q, Reardon, David A, Schiff, David, Drappatz, Jan, Muzikansky, Alona, Grimm, Sean A, Norden, Andrew D, Nayak, Lakshmi, Beroukhim, Rameen, Rinne, Mikael L, Chi, Andrew S, Batchelor, Tracy T, Hempfling, Kelly, McCluskey, Christine, Smith, Katrina H, Gaffey, Sarah C, Wrigley, Brendan, Ligon, Keith L, Raizer, Jeffrey J, Wen, Patrick Y

Volltext

Phase I Trial of Bortezomib and Carboplatin in Recurrent Ovarian or Primary Peritoneal Cancer von AGHAJANIAN, C, DIZON, D. S, SABBATINI, P, RAIZER, J. J, DUPONT, J, SPRIGGS, D. R

Volltext

A phase II trial of PTK787/ZK 222584 in recurrent or progressive radiation and surgery refractory meningiomas von Raizer, Jeffrey J., Grimm, Sean A., Rademaker, Alfred, Chandler, James P., Muro, Kenji, Helenowski, Irene, Rice, Laurie, McCarthy, Katie, Johnston, Sandra K., Mrugala, Maciej M., Chamberlain, Marc

Volltext

A phase II study evaluating the efficacy and safety of AMG 102 (rilotumumab) in patients with recurrent glioblastoma von Wen, Patrick Y., Schiff, David, Cloughesy, Timothy F., Raizer, Jeffrey J., Laterra, John, Smitt, Melanie, Wolf, Michael, Oliner, Kelly S., Anderson, Abraham, Zhu, Min, Loh, Elwyn, Reardon, David A.

Volltext

A phase II trial of erlotinib in patients with recurrent malignant gliomas and nonprogressive glioblastoma multiforme postradiation therapy von Raizer, Jeffrey J., Abrey, Lauren E., Lassman, Andrew B., Chang, Susan M., Lamborn, Kathleen R., Kuhn, John G., Yung, W.K. Alfred, Gilbert, Mark R., Aldape, Kenneth A., Wen, Patrick Y., Fine, Howard A., Mehta, Minesh, DeAngelis, Lisa M., Lieberman, Frank, Cloughesy, Timothy F., Robins, H. Ian, Dancey, Janet, Prados, Michael D.

Volltext

Capecitabine- induced multifocal leukoencephalopathy : A report of five cases von VIDENOVIC, A, SEMENOV, I, RAIZER, J. J, CHUA-ADAJAR, R, BADDI, L, BLUMENTHAL, D. T, BECK, A. C, SIMUNI, T, FUTTERER, S, GRADISHAR, W, TELLEZ, C

Volltext

EGFR phosphorylation of DCBLD2 recruits TRAF6 and stimulates AKT-promoted tumorigenesis von Feng, Haizhong, Lopez, Giselle Y, Kim, Chung Kwon, Alvarez, Angel, Duncan, Christopher G, Nishikawa, Ryo, Nagane, Motoo, Su, An-Jey A, Auron, Philip E, Hedberg, Matthew L, Wang, Lin, Raizer, Jeffery J, Kessler, John A, Parsa, Andrew T, Gao, Wei-Qiang, Kim, Sung-Hak, Minata, Mutsuko, Nakano, Ichiro, Grandis, Jennifer R, McLendon, Roger E, Bigner, Darell D, Lin, Hui-Kuan, Furnari, Frank B, Cavenee, Webster K, Hu, Bo, Yan, Hai, Cheng, Shi-Yuan

Volltext

Metastatic glioblastoma: case presentations and a review of the literature von Kalokhe, Gauri, Grimm, Sean A., Chandler, James P., Helenowski, Irene, Rademaker, Alfred, Raizer, Jeffrey J.

Volltext

A phase II study of bevacizumab and erlotinib after radiation and temozolomide in MGMT unmethylated GBM patients von Raizer, J. J., Giglio, P., Hu, J., Groves, M., Merrell, R., Conrad, C., Phuphanich, S., Puduvalli, V. K., Loghin, M., Paleologos, N., Yuan, Y., Liu, D., Rademaker, A., Yung, W. K., Vaillant, B., Rudnick, J., Chamberlain, M., Vick, N., Grimm, S., Tremont-Lukats, I. W., De Groot, J., Aldape, K., Gilbert, M. R.

Volltext

Brain and leptomeningeal metastases from cutaneous melanoma: survival outcomes based on clinical features von Raizer, Jeffrey J, Hwu, Wen-Jen, Panageas, Katherine S, Wilton, Andrew, Baldwin, Drew E, Bailey, Elizabeth, von Althann, Caroline, Lamb, Lynne A, Alvarado, Gladys, Bilsky, Mark H, Gutin, Philip H

Volltext

Primary CNS lymphoma with intraocular involvement : International PCNSL Collaborative Group Report von GRIMM, S. A, MCCANNEL, C. A, HALL, A. J, GRAUS, F, HERRLINGER, U, SCHIFF, D, RAIZER, J, RUBENSTEIN, J, LAPERRIERE, N, THIEL, E, DOOLITTLE, N, IWAMOTO, F. M, OMURO, A. M. P, ABREY, L. E, FERRERI, A. J. M, BLAY, J.-Y, NEUWELT, E. A, SIEGAL, T, BATCHELOR, T, JAHNKE, K, SHENKIER, T. N

Volltext

Infigratinib in Patients with Recurrent Gliomas and FGFR Alterations: A Multicenter Phase II Study von Lassman, Andrew B, Sepúlveda-Sánchez, Juan Manuel, Cloughesy, Timothy F, Gil-Gil, Miguel J, Puduvalli, Vinay K, Raizer, Jeffrey J, De Vos, Filip Y F, Wen, Patrick Y, Butowski, Nicholas A, Clement, Paul M J, Groves, Morris D, Belda-Iniesta, Cristóbal, Giglio, Pierre, Soifer, Harris S, Rowsey, Steven, Xu, Cindy, Avogadri, Francesca, Wei, Ge, Moran, Susan, Roth, Patrick

Volltext

Multicentre phase II studies evaluating imatinib plus hydroxyurea in patients with progressive glioblastoma von Reardon, D A, Dresemann, G, Taillibert, S, Campone, M, van den Bent, M, Clement, P, Blomquist, E, Gordower, L, Schultz, H, Raizer, J, Hau, P, Easaw, J, Gil, M, Tonn, J, Gijtenbeek, A, Schlegel, U, Bergstrom, P, Green, S, Weir, A, Nikolova, Z

Volltext

Phase I, open-label ascending dose trial of anti–CTLA-4 monoclonal antibody AGEN1884 in advanced solid malignancies, with expansion to patients refractory to recent anti–PD-1/PD-L1... von Wilky, B.A., Kumthekar, P., Wesolowski, R., Hwang, J.J., Park, S.I., Yuan, G., Dupont, C.D., Lim, M., Shebanova, O., Cuillerot, J.-M., Dow, E., Ortuzar, W., Raizer, J.J., Drouin, E., Wilson, N., Gonzalez, A.M., Goldberg, J.M., Buell, J.S., Stein, R.B., Youssoufian, H.

Volltext